Journal Banner

Angioplasty with drug-eluting stents versus bypass grafting for treatment of unprotected left main stem disease.

Medically treated patients with unprotected left main stem (LMS) coronary artery disease have a poor prognosis and early evidence suggests there is a strong survival benefit from surgical revascularization, especially in patients with left ventricular systolic dysfunction.

Author(s): Ramlall M, Costanzo P, Ali A and John J